SecSonar.com

Maravai LifeSciences Holdings, Inc. (MRVI)

Maravai LifeSciences Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Maravai LifeSciences Holdings, Inc. (MRVI) is a Biotechnology company based in US with a market capitalization of $1.3B. Revenue declined 28.3% year-over-year and free cash flow was negative at -$70.7M. This page tracks MRVI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 570 employees · IPO Nov 20, 2020

Valuation

Valuation & price

$4.15 · as of May 17, 2026 · -35.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

6.32

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.11$4.07$2.04Jul 25Dec 25Jun 26Jul 7, 25$2.60Jul 9, 25$2.76Jul 11, 25$2.73Jul 15, 25$2.59Jul 17, 25$2.51Jul 21, 25$2.38Jul 23, 25$2.62Jul 25, 25$2.69Jul 29, 25$2.48Jul 31, 25$2.34Aug 4, 25$2.27Aug 6, 25$2.04Aug 8, 25$2.20Aug 12, 25$2.69Aug 14, 25$2.60Aug 19, 25$2.51Aug 21, 25$2.39Aug 25, 25$2.40Aug 27, 25$2.33Aug 29, 25$2.42Sep 3, 25$2.36Sep 5, 25$2.51Sep 9, 25$2.66Sep 11, 25$2.79Sep 15, 25$2.72Sep 17, 25$2.81Sep 19, 25$2.70Sep 23, 25$2.74Sep 25, 25$2.69Sep 29, 25$2.83Oct 2, 25$2.97Oct 6, 25$3.12Oct 8, 25$3.33Oct 10, 25$3.19Oct 14, 25$3.23Oct 16, 25$3.49Oct 20, 25$3.52Oct 22, 25$3.41Oct 24, 25$3.41Oct 28, 25$3.23Oct 30, 25$3.14Nov 3, 25$2.94Nov 5, 25$2.87Nov 7, 25$2.87Nov 11, 25$3.25Nov 14, 25$3.64Nov 18, 25$3.62Nov 20, 25$3.42Nov 24, 25$3.68Nov 26, 25$3.64Dec 1, 25$3.38Dec 3, 25$3.51Dec 5, 25$3.70Dec 9, 25$3.69Dec 11, 25$3.71Dec 15, 25$3.67Dec 17, 25$3.46Dec 19, 25$3.43Dec 23, 25$3.29Dec 26, 25$3.27Dec 31, 25$3.25Jan 5, 26$3.79Jan 7, 26$3.86Jan 9, 26$3.93Jan 13, 26$4.02Jan 15, 26$3.69Jan 20, 26$3.75Jan 22, 26$3.83Jan 26, 26$3.70Jan 28, 26$3.42Jan 30, 26$3.36Feb 3, 26$3.26Feb 5, 26$3.09Feb 9, 26$3.11Feb 11, 26$3.12Feb 17, 26$2.93Feb 19, 26$3.08Feb 23, 26$3.06Feb 25, 26$3.26Feb 27, 26$3.56Mar 3, 26$3.69Mar 5, 26$3.68Mar 9, 26$3.63Mar 11, 26$3.55Mar 13, 26$3.08Mar 17, 26$3.12Mar 19, 26$3.03Mar 23, 26$3.07Mar 25, 26$3.11Mar 27, 26$2.86Apr 1, 26$2.87Apr 6, 26$2.95Apr 8, 26$3.11Apr 10, 26$3.07Apr 14, 26$3.28Apr 16, 26$3.41Apr 20, 26$3.61Apr 22, 26$3.69Apr 24, 26$3.55Apr 28, 26$3.56Apr 30, 26$3.68May 4, 26$3.79May 6, 26$3.94May 8, 26$4.85May 12, 26$4.66May 15, 26$4.15May 19, 26$4.22May 21, 26$4.48May 26, 26$4.38May 28, 26$4.64Jun 1, 26$4.75Jun 3, 26$4.84Jun 5, 26$5.02Jun 9, 26$5.10Jun 11, 26$5.21Jun 15, 26$4.96Jun 17, 26$5.22Jun 22, 26$5.25Jun 24, 26$5.76Jun 30, 26$6.11
$2.0352-week range$6.39
Loading valuation history…

Fundamentals

Key fundamentals

$1.3B

Market cap

-28.3%

Revenue growth (YoY)

18.0%

Gross margin

-$70.7M

Free cash flow (USD)

-$181.3M

Net debt

Net cash position

5.2%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$123.8MFY 2019$143.1MFY 2020$284.1MFY 2021$799.2MFY 2022$883.0MFY 2023$288.9MFY 2024$259.2MFY 2025$185.7M
$123.8M$185.7M

Free cash flow by year

2018 → 2025

FY 2018$-3.8MFY 2019$7.0MFY 2020$126.8MFY 2021$353.7MFY 2022$518.9MFY 2023$60.7MFY 2024$-22.2MFY 2025$-70.7M
-$3.8M-$70.7M

Gross margin by year

2021 → 2025

FY 202182.4%FY 202280.9%FY 202348.5%FY 202441.8%FY 202518.0%
82.4%18.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $254K · 10b5-1 PlanORESHACK KURT · General Counsel · $254KJun 10, 2026Filing
  • 8-K eventCredit Agreement ExecutedJun 3, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 29, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing

Questions

Frequently asked questions

What is Maravai LifeSciences Holdings, Inc.'s market cap?

Maravai LifeSciences Holdings, Inc. (MRVI) has a market capitalization of $1.3B.

What is MRVI's P/E ratio?

A meaningful P/E ratio is not available for MRVI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MRVI's price-to-book (P/B) ratio?

MRVI trades at 6.32 times book value per share.

Are insiders buying MRVI stock?

SEC Form 4 filings show no open-market insider buys at Maravai LifeSciences Holdings, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

PGEN

Precigen, Inc.

$1.3B

SEPN

Septerna, Inc.

$1.4B

CAPR

Capricor Therapeutics, Inc.

$1.4B

URGN

UroGen Pharma Ltd.

$1.4B

WVE

Wave Life Sciences Ltd.

$1.3B

GLUE

Monte Rosa Therapeutics, Inc.

$1.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.